Grants & Programs
Annually, the LCF board selects an assortment of Kentucky cancer patient services and cancer research programs to award funding to through a grant process. LCF has awarded and pledged millions of dollars for cancer research, education and care, impacting all 120 Kentucky counties. Funding has benefited patients of breast cancer, colon cancer, prostate cancer, lung cancer, pediatric cancer and much more. Grant awards support numerous projects, including cancer patient transportation to medical centers, cancer prevention programs, free prostate screenings, Jin Shin Jyutsu sessions for patients, summer camp experiences for children battling cancer, and much more.
Each spring, non-profits, medical centers, and cancer organizations are invited to complete a grant application. The process includes clear guidelines on criteria that must be met and information that must be provided to LCF before funds are granted. The application protocol assures that funding supports the LCF mission and vision.
Any organization that addresses cancer in the Commonwealth of Kentucky is invited to apply. The Grant Application can be accessed here or by calling the office at 859.388.2620. The grant deadline is September 30, 2023, by postmark or email. Please submit additional information, as needed, to support your grant application.
Grant applications can be submitted by email (preferred to email@example.com) or in hard copy format to: 1504 College Way, Lexington, KY 40502.
A grant committee reviews each submitted grant application during the month of October this year. Additionally, all research grant applications are reviewed by the LCF’s Medical Advisory Board. A written report is provided to LCF by the board.
The grant committee presents funding recommendations to the full board for approval. Grant acceptance and decline letters will be sent as soon as board approval is given. The LCF office will contact each applicant as soon as the decisions are made. Please do not call the office inquiring about your grant submission.